| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |